Royalty Pharma plc
Royalty Pharma acquires biopharmaceutical royalties and funds innovation across the industry.
8-KSep 23Latest SEC filing, period to Sep 23
Aug 5Latest story
August 2026
Royalty Pharma acquires biopharmaceutical royalties and funds innovation across the industry.